Outlook Therapeutics, Inc.

US$0.44As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:OTLKHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (51.94%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.72
PE TTM —
TSR TTM (65.37%)
Mkt cap US$106.2M
ROIC (1253.84%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.532
21.97%
(81.90%)
Hold 10|5|3|5|12
1Q26
2Q26
3Q26
4Q26
Earnings per share$
—
—
—
—
18.73%
9.10%
(0.92%)
(8.97%)
Revenue$M
5.364
5.538
5.551
5.596
0.54%
4.58%
5.94%
9.98%
Peers (US$106.2M)
Cap (US$)
PE
105.7M
—
Capital
TTM
5Y
10Y
Leveragex
0.827
(0.918)
(0.682)
EBIT/Intx
0.905
0.261
0.202
Own earn%
(249.51)
59.32
70.14
Sh yield%
31.84
34.63
34.44
Owners
Insiders/Inst%
2.40
20.79
Short interest%
5.15
SBC / revenue%
2.10
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
12–15
$1 testx
0.0
Incr. ROIC%
19